Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invested in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The Company's portfolio consists of pharmaceutical products with molecules and includes both in-licensed products, such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome as well as products owned (or partially owned) by it, such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > Samira purchased 20,000 shares & 425,000 options expire

<< Previous

Bullboard Posts

Next >>

Comment by MrMugsyon Mar 31, 2022 12:40pm

88 Views

Post# 34563528

RE:RE:RE:RE:Samira purchased 20,000 shares & 425,000 options expire

You might be right Chi-Chi but what's your point? Where do you want to take that idea?

Keep in mind that while the price is lower than the option price, those people have been buying at market. They're still accumulating shares and getting a better price.

I know you don't like that - but - that's the way it is.

I know you bought your shares at $10 Chi-Chi (Cluey) ... but ... at what price did you sell your shares ?

<< Previous

Bullboard Posts

Next >>

2024, a breakthrough year for silver